POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (8.3.2021, 5:30pm CEST, WHO):   U.S. 15,081    India 30,549    Brazil 20,503    Russia 22,010    France 1,996    The United Kingdom 21,687    Turkey 22,898    Argentina 6,083    Columbia 9,094    Spain 4,954    Italy 3,185    Iran 37,189    Germany 1,766    Indonesia 33,900    Mexico 6,740    South Africa 5,574    Peru 1,808    The Netherlands 2,136    Iraq 12,734    Philippines 8,167    Bangladesh 15,776    Malaysia 15,764    Pakistan 4,858    Portugal 1,190    Japan 8,877    Israel 1,326    Nepal 2,448    United Arab Emirates 1,537    Thailand 18,901    Morocco 4,206    Tunisia 1,243    Saudi Arabia 1,063    Georgia 4,827    Cuba 9,279    Myanmar 4,713    Ireland 1,352    Libya 2,892    South Korea 1,202    Algeria 1,358    Mongolia 1,019    Vietnam 7,832    Mozambique 1,421    Zimbabwe 1,309    Ghana 1,975    Réunion 3,014    Fiji 1,100    China 107    Singapore 111    New Zealand 1    Australia 229   

Taiwan approves Medigen's COVID-19 vaccine candidate

Christian Fernsby |
Taiwan's government on Monday approved the use and production of Medigen Vaccine Biologics Corp's 6547.TWO COVID-19 vaccine candidate.

Article continues below




Taiwan-based Medigen said last month it was seeking a speedy emergency use authorisation, or EUA, from the government for its vaccine candidate after safely completing Phase II trials.

The health ministry said in clinical trials in Taiwan the antibodies created by Medigen's vaccine candidate have been proven to be "no worse than" those created by AstraZeneca vaccines, and that there were no major safety concerns.

The ministry added that Medigen had to present a monthly report on safety for the vaccine candidate, MVC-COV1901, which is designed for people aged over 20, who will get two shots 28 days apart.

Health Minister Chen Shih-chung told reporters that with the EUA approved, it would now take some time for the company to ramp up its production.


What to read next

World-first COVID-19 alternating dose vaccine study launches in UK
WHO validates Sinovac COVID-19 vaccine for emergency use
'We are not China': Vietnam lifts ban on Taiwan flights, Wuhan coronavirus mess